Early research (Phase 1)UnknownNCT02380079What this trial is testingDose-Escalation Study of SCD-101 in Sickle Cell DiseaseWho this might be right forSickle Cell DiseaseSickle-Beta Zero Thalassemia Invenux, LLC 60
Testing effectiveness (Phase 2)Study completedNCT00601718What this trial is testingVorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+34 more University of Washington 29
Testing effectiveness (Phase 2)UnknownNCT00363090What this trial is testingAlemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma Toronto Sunnybrook Regional Cancer Centre 84
Testing effectiveness (Phase 2)Study completedNCT02997761What this trial is testingIbrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic LeukemiaWho this might be right forAdult B Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive University of California, Davis 19
Testing effectiveness (Phase 2)Looking for participantsNCT05658640What this trial is testingHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more Princess Maxima Center for Pediatric Oncology
Large-scale testing (Phase 3)Ended earlyNCT04817761What this trial is testingSPARK-ALL: Calaspargase Pegol in Adults With ALLWho this might be right forAcute Lymphoblastic Leukemia Institut de Recherches Internationales Servier 42
Testing effectiveness (Phase 2)Study completedNCT00058305What this trial is testingBryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell TransplantationWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+9 more National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05283720What this trial is testingEvaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Genmab 264
Early research (Phase 1)Looking for participantsNCT05131022What this trial is testingNX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Diffuse Large B Cell Lymphoma (DLBCL)+6 more Nurix Therapeutics, Inc. 572
Testing effectiveness (Phase 2)Study completedNCT00795769What this trial is testingOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)Ended earlyNCT01159067What this trial is testingDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadWho this might be right forIron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more City of Hope Medical Center 1
Not applicableStudy completedNCT01563861What this trial is testingS9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 397
Not applicableEnded earlyNCT00504205What this trial is testingMP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific Astex Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00005631What this trial is testingRituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Very early researchStudy completedNCT01959477What this trial is testingDose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell TransplantWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+142 more Case Comprehensive Cancer Center 33
Testing effectiveness (Phase 2)UnknownNCT00039156What this trial is testingBAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Theradex
Not applicableWithdrawnNCT04541875What this trial is testingMedication Adherence and Non-adherence in Adults With Rare DiseaseWho this might be right forCystic FibrosisHemophilia AHemophilia B+3 more Xperiome
Not applicableLooking for participantsNCT06131801What this trial is testingPharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a SolutionWho this might be right forHematologic MalignancyLeukemiaLymphoma+16 more Children's Hospital Medical Center, Cincinnati 30
Early research (Phase 1)Ended earlyNCT02900651What this trial is testingSafety and Efficacy of MAK683 in Adult Patients With Advanced MalignanciesWho this might be right forDiffuse Large B-cell Lymphoma Novartis Pharmaceuticals 139
Early research (Phase 1)Ended earlyNCT00103272What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic CancerWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more National Cancer Institute (NCI) 74